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OrganelleOne solution found in evolution to increase the number of cellular functions, without increasing the number
of genes, is distribution of single gene products to more than one cellular compartment. It is well
documented that in eukaryotic cells, molecules of one protein can be located in several subcellular locations,
a phenomenon termed dual targeting, dual localization, or dual distribution. The differently localized
proteins are coined in this review “echoforms” indicating repetitious forms of the same protein (echo in
Greek denotes repetition) distinctly placed in the cell. This term replaces the term to “isoproteins” or
“isoenzymes” which are reserved for proteins with the same activity but different amino acid sequences.
Echoforms are identical or nearly identical, even though, as referred to in this review may, in some cases,
surprisingly have a totally different function in the different compartments. With regard to mitochondria,
our operational deﬁnition of dual targeted proteins refers to situations in which one of the echoforms is
translocated through/into a mitochondrial membrane. In this review we ask how, when and why
mitochondrial proteins are dual localized in the cell. We describe mechanisms of dual targeting of proteins
between mitochondria and other compartments of the eukaryotic cell. In particular, we have paid attention
to situations in which dual localization is regulated in time, location or function. In addition, we have
attempted to provide a broader view concerning the phenomenon of dual localization of proteins by looking
at mechanisms that are beyond our simple deﬁnition of dual targeting. This article is part of a Special Issue
entitled Protein translocation across or insertion into membranes.translocation across or insertion into membranes.
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Table 1
Dual targeting mechanisms of mitochondrial protein.
Dual targeting
mechanism
Genes mRNAs Translation
products
Examples in
this reviewa
Illustrated
in ﬁgure
Two genes encode
two isoprotein:
one that contains
a targeting signal
which the
other lacks.
2 2 2 MdhYM
AconitaseM
1A
Two transcripts are
created by
alternative
transcription
initiation or
alternative
splicing, which
removes a
targeting signal.
1 2 2 Hts 1Y,
Vas 1Y,
ReninM
1B
Translation
initiation from
in-frame start
codons, which
removes a
targeting signal.
1 1 2 Mod5Y,
Pol
gamma 2P,
Hcs 1P
1C
An ambiguous
targeting signals
is recognized by
two organelles.
1 1 1 TyrRSP,
LpSodP,
NADH-
cytochrome
b5RM,
Fis 1M
2A
Two targeting
signals on one
protein target it
to two organelles.
1 1 1 NAD(P)H
dehydrogenaseM,
CYP2B1M
2B
Targeting sequence
is inaccessible in
some of the
protein
molecules.
1 1 1 Aky2Y,
Apn 1Y,
ERSY,
CYP2B1M,
Cyp1A1M
2C
Reverse
translocation of
some of the
protein
molecules.
1 1 1 FumaraseY,
NFS1Y,
AconitaseY
2D
Membrane
permeabilization,
release or export
of proteins
1 1 1 Cytochrome CM,
HSP60M,
MortalinM
2E
a Y, Yeast; M, Mamalian; P, Plants.
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Eukaryotic cells are deﬁned by the existence of subcellular
compartments and organelles. This allows the partitioning of various
biochemical pathways out of the cytosolic milieu into discrete
organelles. For this, each cellular compartment has a speciﬁc protein
content that is vital for its function. Mitochondria are such organelles,
which are responsible for energy production and essential metabolic
pathways in the cell, and these organelles have been implicated in
other processes such as apoptosis, aging and cancer.
Sorting of proteins to a membrane-sealed organelle, such as
mitochondria, involves twomain steps: i) Targeting of proteins to and
speciﬁc recognition by the organelle and ii) Translocation into the
organelle, through or into its membranes by an import machinery.
This necessitates that the protein includes targeting and translocation
information within its sequence that is recognized by the organelle
receptors and import machinery. In this review we intentionally do
not provide an introduction to protein targeting information within
substrates and protein translocation machineries within cells. These
are provided by excellent accompanying reviews in this issue dealing
with protein targeting and translocation in mitochondria, chloro-
plasts, peroxisomes and the ER.
It iswell documented that in eukaryotic cellsmolecules of oneprotein
can be located in several subcellular locations, a phenomenon termed
dual targeting, dual localization or dual distribution. The differently
localized proteins are termed isoproteins. With regard to mitochondria,
our conventional deﬁnition of dual targeted proteins refers to situations
in which one of the isoproteins is translocated through/into a
mitochondrial membrane. Thus, dual targeted proteins are recognized
by at least one organelle's receptors and translocation machineries.
Dually targeted proteins can be located in two or more compart-
ments, immediately after translation thereby creating a steady state
ratio between the different sub-populations. In recent years it has
become evident that dual targeting can be regulated; induced or
rebalanced in response to cellular signaling or as a response to
changing extracellular conditions. Interestingly, these proteins can
perform the same or distinct activities and functions in each location.
Dual targeting of proteins in eukaryotic cells is a timely topic for
which several excellent reviews have been published in the last
decade on different aspects of this phenomenon [1–9]. In this review,
we describe mechanisms of dual targeting of proteins between
mitochondria and other compartments of the eukaryotic cell. We have
addressed situations inwhich dual targeting of proteins is regulated in
time, location or function; for instance, changes in targeting under
speciﬁc cellular conditions, changes in the relative amounts of the
isoproteins, and additional new functions performed by one of the
isoproteins. Due to the large number of studies dealing with dual
targetingwe have chosen in each case one or two examples in order to
make a point, with the understanding that this choice was oftentimes
fortuitous or subjective based on our familiarity and knowledge. In
some cases while the data suggests dual localization of a protein, the
mechanism by which this occurs is unknown and therefore open
questions linger.
The review will deal with dual targeting mechanisms of mito-
chondrial proteins that are based on single or multiple translation
products (Table 1). In addition, we provide a broader view concerning
the phenomenon of dual localization of proteins by looking at
mechanisms that are beyond our simple deﬁnition of dual targeting.
2. Dual targeting mechanisms of mitochondrial proteins
2.1. Two (or more) translation products
2.1.1. Two or more genes
The simplest and most basic mechanism for achieving dual
targeting is the existence of two genes. In this case, each gene canencode a slightly different isoprotein; one that contains a targeting
signal which the other lacks. This allows the creation of two
translation products that are targeted to two cellular locations
(Fig. 1A). Examples for this mechanism can be found in the yeast
malate dehydrogenases (MDH) and alcohol dehydrogenases (ADH).
Saccharomyces cerevisiae contains 3 highly homologous isozymes of
malate dehydrogenase. All three catalyze the interconversion of
malate and oxaloacetate. While sharing the same enzymatic activity,
each isoenzyme is located in a separate compartment; MDH1
participates in the tricarboxylic acid cycle in mitochondria, MDH2
functions in the cytosol as part of the malate/aspartate shuttle and
MDH3 catalyzes the reaction as part of the glyoxylate shunt in
peroxisomes [10–13]. The same phenomenon can be found in higher
eukaryotes where MDH is encoded by two genes MDHI and MDHII,
located in the cytosol and mitochondria respectively [14–16].
A second example, from higher eukaryotic cells, is the protein
aconitase. Two proteins are encoded by two genes ACO1 and ACO2;
Aco2 is a mitochondrial enzyme of the Krebs cycle and Aco1 is a
cytosolic participant in cellular iron regulation. In the case of
aconitase, the two isoproteins differ in their location and also in
their function. While Aco2 is an enzyme that catalyzes the conversion
Fig. 1. Dual targeting mechanisms based on two translation products. Mechanisms by which two isoproteins derived from two translation products are dual targeted in the
eukaryotic cell. (A) Two genes, of which only one encodes a mitochondrial-targeting signal (MTS). (B) Two mRNAs from a single gene of which only one encodes an MTS; obtained
either by alternative transcription initiation (arrows) or by splicing (scissors). (C) Two proteins from a single mRNA of which only one harbors the MTS; obtained by alternative
translation initiation (ribosomes attached at initiation codons). The DNA, RNA and polypeptide specifying the MTS are colored in orange.
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mentioning is that in yeast the single translation product of aconitase
has been shown to also bind mitochondrial DNA, and takes part in
stabilization of themitochondrial genome [18]. Thus in both yeast and
human cells aconitase binds nucleic acids as a function distinct from
its enzymatic activity.
2.1.2. One gene multiple mRNAs
Dual targeting can occur due to the existence of multiple mRNAs
that are derived from a single gene. This can be achieved either by
alternative transcription initiation or by mRNA splicing. In both cases
two (or more) translation products are made and are targeted to
different cellular locations (Fig. 1B).
In yeast the histidine tRNA synthetase (HTS1) and valyl-tRNA
synthetase (VAS1) are localized both to the cytosol and tomitochondria.
The corresponding genes encode two transcripts: a long one, which
includes the mitochondrial-targeting sequence, that is translated into
themitochondrial form of the protein, and a short one that is translated
into the cytosolic form that lacks this signal [19–21].
An example involving splicing in higher eukaryotes can be found
in the case of the rat renin which is dual targeted to mitochondria and
the ER [22]. The renin gene encodes two transcripts: a full-length
transcript that encodes an ER N-terminal targeting signal, and a
second shorter one, whose alternative transcription initiation and
alternative splicing remove the ER targeting signal. This allows a
cryptic mitochondrial-targeting sequence found downstream (be-
tween amino acids 36 and 50) to function in targeting of renin to
mitochondria.
2.1.3. One mRNA multiple translation products
OnemRNA can give rise to several proteins by translation initiation
from several in-frame start codons. In this case the full-length protein
includes an N-terminal targeting sequence while the shorter lacks it
and may or may not contain a second targeting sequence (Fig. 1C).
Thus the mechanism is based on the ability of the ribosome to skip of
the ﬁrst AUG, which can be affected by the sequence context
surrounding the AUG (Kozak) and/or by RNA secondary structures
in the vicinity of the AUG.
MOD5, which is encoded by a single gene, was found to localize to
the mitochondria, cytosol and nucleus. This gene encodes a single
mRNA, which contains two translation initiation sites. Translation
from these sites leads to the synthesis of two translation products: along one (from ATG1) harboring amitochondrial-targeting signal, and
a short one (from ATG12) that lacks the functional signal [23].
Accordingly, each of the translation products was localized different-
ly; the full-length polypeptide is found predominantly in mitochon-
dria while the short translation product, which is absent from
mitochondria, is found in the cytosol and the nucleus.
An example in which we can discuss different parameters, which
can affect alternative translation initiation that allows dual targeting,
is the DNA polymerase POLgamma2 in plants. This gene's translation
initiates at four distinct sites, to produce distinct plastid and
mitochondria-targeted forms of the protein. The mechanism is
based on alternative translation initiation due to leaky ribosome
scanning in which the ribosomes skip some of the start codons. In the
case of POLgamma2 there are four in-frame translation initiation
sites: two AUGs and two upstream non-AUG start codons. At all these
translation initiation sites there is only a partial Kozak consensus
sequence. This leaky scanning also relies on the less efﬁcient upstream
non-AUG start codons, and in fact substitution of these non-AUG sites
for AUG eliminates translation from the downstream AUG sites.
Moreover, ribosome binding to the upstream non-AUG sites depends
on sequences surrounding these start sites; deletion of the non-coding
upstream sequence leads to translation only from the AUG sites and to
an exclusive plastid localization. Nevertheless translation only from
the upstream sites leads to a protein with an ambiguous (see
deﬁnition below) targeting sequence, while the short version includes
an N-terminal exclusive plastid targeting sequence [9,24]. Hence, dual
targeting in this case is determined by the nature of the translation
initiation codons and surrounding sequences. An interesting example
regarding an upstream sequence that can affect translation initiation,
is the Arabidopsis HCS1. Splicing out of 101 bases from the
untranslated 5′UTR affects AUG choice for translation initiation and
results in the production of a full-length protein harboring a
chloroplast/mitochondrial-targeting signal (see below) and a shorter
cytosolic protein that lacks it [25].
2.2. Single translation product
The most interesting and complicated dual targeting mechanisms
are those that allow a single translation product to be localized tomore
than one compartment. The ability of one protein to be recognized by
and translocated into more than one compartment can be achieved by
several distinct mechanisms.
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Some proteins have an ambiguous targeting sequence that can be
recognized by more than one organelle (Fig. 2A). In this case, protein
localization will be determined by “competition” between the
organelles for the signal. The ratio between the protein sub-
populations, in this case is determined by the afﬁnity of the receptors
of each organelle for this sequence. Recently there are an increasing
number of reports on dual localization of proteins to mitochondria
and chloroplasts [1,26,27]. The amino acid composition of mitochon-
drial and chloroplast targeting sequences is similar, with high
abundance of hydroxylated, hydrophobic, and positively charged
amino acids and low abundance of negatively charged residues. In this
regard the targeting sequence of amino acyl-tRNA synthetases was
analyzed in Arabidopsis [28]. For three of the proteins (TyrRS, ValRS,
and ThrRS) deletionswithin this targeting sequence affected targeting
to mitochondria and chloroplasts similarly. For two other proteins
(ProRS and AspRS) the deletions remove either chloroplast or
mitochondrial-targeting information without abolishing the respec-
tive alternative targeting signal. While the ﬁrst two examples are
consistent with a true ambiguous signal with overlapping informa-
tion, the two latter cases are examples of separate targeting signals to
chloroplasts and mitochondria placed in tandem.
Ambiguous targeting signals are not restricted to mitochondria
and chloroplasts as for example in the case of iron-containing
superoxide dismutase (LpSOD). In addition to the mitochondria/ER
ambiguous signal its mRNA contains two in-frame AUG start codons.
Translation initiation from the ﬁrst AUG enables the creation of the
full-length protein that contains the N-terminus targeting signal. This
is an ambiguous signal since it harbors both a weak ER signal peptide
and a mitochondrial-targeting signal. If the synthesized polypeptide
binds the signal recognition particle (SRP) it will be imported into the
ER co-translationally. On the other hand if the polypeptide binds theFig. 2. Dual targeting mechanisms based on a single translation product. Mechanisms by w
eukaryotic cell. (A) An ambiguous targeting signal is recognized by two organelles. (B) Com
targeting signal accessibility. (C1) A cytosolic protease cleaves the nascent chain thereby
targeting; caused by (i) folding, (ii) binding to cellular factors or (iii) modiﬁcation of the po
moves back to the cytosol during import. (E) Release of proteins from mitochondrial intermnascent polypeptide-associated complex (NAC) the protein will be
post-translationally imported into mitochondria. Translation initia-
tion from the second AUG gives rise to the synthesis of a shorter
version, lacking the N-terminal ambiguous targeting signal. This latter
protein is synthesized in the cytosol and then targeted to the
peroxisome due to a C-terminal targeting signal [29]. So, this protein
is localized to three different subcellular compartments employing
two mechanisms: alternative translation initiation and an ambiguous
targeting signal.
In some cases the afﬁnity of an ambiguous targeting signal to the
different compartments can be changed by modiﬁcation or binding of
other proteins. An example for modiﬁcation of an ambiguous targeting
sequence can be found in the mammalian NADH–cytochrome b(5)
reductase (b5R). This protein is localized both to the mitochondrial
outer membrane and to the ER membrane. On the ER membrane it
participates in different aspects of lipidmetabolismvia its function as an
electron acceptor. On the mitochondrial outer membrane it mediates
the regeneration of ascorbate fromascorbate free radical and is involved
in transfer of electrons from cytosolic NADH to cytochrome c in the
intermembrane space. This protein is translated from a single mRNA to
create a single translation product, harboring an N-terminal targeting
signal, required for both ER and mitochondrial targeting. This signal
contains a moderately hydrophobic stretch of 14 amino acids that is
preceded by amyristoylation consensus sequence, which is modiﬁed in
about half of themolecules. In the absenceofmyristoylation, thenascent
chain is bound to the SRP and is targeted to the ER.Myristoylation of the
N-terminus lowers the afﬁnity of the signal for SRP; the nascent chain
remains on free polysomes and is imported post-translationally into the
mitochondria [30].
Human Fis1 is an example of a C-terminal ambiguous signal, which
is affected by the binding of another protein. This tail-anchored
membrane protein regulates the membrane ﬁssion of bothhich two isoproteins derived from a single translation product are dual targeted in the
petition between two targeting signals on the same polypeptide. (C) Changes in the
exposing a cryptic targeting signal. (C2) Inaccessibility of a signal prevents protein
lypeptide. (D) Reverse translocation of the protein; a sub-population of the molecules
embrane space by membrane permeabilization.
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last 26 amino acids, to bind Pex19p, a peroxisomal membrane protein
import factor or alternatively function as a mitochondrial tail anchor.
Interestingly, down-regulation of Pex19p reduces peroxisome target-
ing but not targeting to mitochondria, suggesting that targeting to
mitochondria and peroxisomes are independent events even though
both are dependent on the same C-terminal sequence [31].
2.2.2. Two targeting signals
Two (or more) targeting signals on a single polypeptide can
provide themechanism of dual targeting (Fig. 2B). Here the balance of
isoprotein amounts between the different organelles is determined by
the afﬁnity of each signal for its target.
In Arabidopsis, 7 genes encode type II NAD(P)H dehydrogenases
(ND). These proteins are typically located in the mitochondrial inner
membrane where they can oxidise NAD(P)H. Three of these proteins
were shown to be dual targeted to mitochondria and peroxisomes.
Dual targeting of these three is dictated by two targeting signals: an
N-terminal mitochondrial-targeting signal and a C-terminal peroxi-
somal targeting signal [32].
In some cases, the afﬁnity of each targeting sequence for its target can
be altered by proteinmodiﬁcation,which in turn can change the relative
amounts of the subcellular populations of the protein. The phenobar-
bital-inducible mitochondrial and microsomal CYP2B1 is targeted both
to the ER andmitochondria by an amino-terminal bipartite signal, which
includes an ER targeting sequence followed by a cryptic mitochondrial-
targeting sequence. Dual targeting of CYP2B1 apoproteins to the ER and
to mitochondria is modulated via a cAMP-dependent protein kinase A
site. Phosphorylation of ser128 reduces the afﬁnity of the protein for SRP
and increases its afﬁnity for the mitochondrial import machinery. This
mechanism allows the cell to tilt the balance between two cellular
compartments, according to cellular cAMP levels, which is a major
constituent of cellular signaling [33].
2.2.3. Accessibility of targeting signals
Single translation products harboring one or more speciﬁc
targeting signals can be dual targeted due to a situation in which one
of the signals is inaccessible. In these cases all of the protein harbors a
targeting sequence; however, for a sub-population of the molecules
the signal becomes inaccessible, thereby preventing its interaction
with its speciﬁc receptor (Fig. 2C). Inaccessibility of the targeting
sequence can be caused by folding of the protein (i) interaction of the
protein with other proteins (ii) or by modiﬁcation of the polypeptide
chain (iii). For example, yeast adenylate kinase 2 (Aky2) is located in
the cytosol and the mitochondrial intermembrane space. Its rapid
folding hinders the accessibility of the targeting signal to the
mitochondrial receptor in some of the molecules and these molecules
are localized in the cytosol. In this case competition between folding
and targeting determines protein localization [34].
In a previous review we have referred to the protein Apurinic/
apyrimidinic endonuclease 1 (Apn1) [2,35] as an example of
inaccessibility of a signal caused by protein binding. Brieﬂy, the
protein Pir1 binds to Apn1 therebymasking its NLS and thus enhances
mitochondrial targeting of the protein. This is an example of a signal
whose accessibility is determined by the binding of another protein.
Another example for this type of mechanism is Glutamyl-tRNA
synthetase (ERS) in yeast which is localized to the cytosol and
mitochondria. Import into mitochondria is due to a noncanonical MTS
located after the ﬁrst 190 residues. Binding to Arc1p, a protein that
serves as a cytoplasmic anchoring platform, prevents the import and
sequesters a major portion of ERS in the cytoplasm (in its absence all
molecules are located in mitochondria). Arc1p levels are decreased in
response to a switch between fermentation to respiratory metabo-
lism, increasing as a result the mitochondrial ERS and mitochondrial
protein synthesis. Thus Arc1 allows the cells to switch betweenfermentation and respiration by changing the cellular localization of
Glutamyl-tRNA synthetase [36].
Examples given in previous sections, myristoylation of b5R and
phosphorylation of CYP2B1, may also fall into this category of affecting
accessibility of signals by covalentmodiﬁcation of the polypeptide chain
(Fig. 2Ciii). An interesting example is CYP1A1, in which not only does
polypeptidemodiﬁcationmake one of the signals inaccessible it actually
removes this signal from the protein by cleavage of the protein
(Fig. 2C1). CYP1A1 harbors an N-terminal ER targeting signal followed
by a cryptic mitochondrial-targeting signal. The primary translation
product of the protein, according to its N-terminal signal, is targeted to
the ER.While themajority of themolecules are translocated into the ER,
25% of them escape ER membrane insertion and are cleaved by a
cytosolic protease, thereby activating a cryptic mitochondrial-targeting
sequence [37]. Thus, the distribution of CYP1A1 can be regulated by
inducing the protease (e.g. with b-naphthoﬂavone). Intriguingly the
distribution of other proteins such as the glucocorticoid receptor, the
retinoid X receptor, and p53, between mitochondria and other cellular
compartments, may be dependent on cleavage of the protein by this
serine protease and the distribution is probably determined by a
mechanism similar to CYP1A1.
2.2.4. Reverse translocation
A unique dual targeting mechanism is based on retrograde
movement of the protein during its import (Fig. 2D). The well-
documented example of this mechanism is the enzyme fumarase in
the yeast S. cerevisiae. In this case, all molecules are ﬁrst targeted to
mitochondria, begin their translocation and are processed by MPP.
Nevertheless, a sub-population of the molecules moves back to the
cytosol. Thedriving force for this distribution is protein folding; if during
import the nascent chain starts to fold in the mitochondrial matrix, it
will complete its import and be localized in mitochondria. On the other
hand if the nascent chain starts its folding in the cytosol, thereby
blocking its forward movement, the protein will withdraw from the
import machinery, andwill be localized in the cytosol [38]. Intriguingly,
metabolic cues originating from the glyoxylate shunt can affect the ratio
of mitochondrial versus cytosolic levels of fumarase. Deletions of
glyoxylate shunt genes or addition of succinate, (a product of the
glyoxylate shunt) to the yeast growthmediumcauses a shift of fumarase
to mitochondria [39]. This suggests an interesting connection between
primary metabolism pathway and protein localization.
Recently two other proteins were shown to be dual targeted in S.
cerevisiae by a reverse translocation mechanism, Nfs1 and Aco1.
Aconitase is dual localized to mitochondria and the cytosol, while Nfs
is localized to mitochondria and the nucleus [40,41]. In this regard the
sequence of the MTS can tilt the balance between the two locations of
aconitase (and fumarase). The mechanism suggested is that the
mitochondrial-targeting signal affects the translocation rate thereby
determining the time (opportunity) required for the protein to fold or
bind factors in the cytosol that block import [42].
2.2.5. Membrane permeabilization, release or export of proteins
The mechanism by which mitochondrial proteins, under speciﬁc
conditions, can be found outside the organelle is not fully understood.
This is particularly disturbing since an export apparatus of proteins
out of mitochondria has not been described. The breakdown of the
outer membrane or both inner and outer membranes could be a
source for such proteins following induction of apoptosis or
mitophagy (Fig. 2E). Following certain stress conditions such as
hypoxia and DNA damage, the intrinsic apoptosis pathway is
characterized by recruitment of cytosolic pro-apoptotic proteins to
the mitochondrial outer membrane, membrane permeabilization, and
release of potent death factors from the intermembrane space into the
cytosol (reviewed in refs. [43,44]). A well-known example for this
mechanism is the release of cytochrome c from the intermembrane
space, during the intrinsic apoptosis pathway [45]. Thus, cytochrome
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in the caspase activation cascade; cytochrome c binds ARF in the
cytosol, which leads to activation of caspase-9 and in turn caspase-3.
Whether cytochrome c passes through a channel such as the porin
VDAC or whether the outer membrane is disrupted is still under
debate [46].
It is hard to explain detection of certain well-known mitochondrial
proteins at unexpected extramitochondrial sites in the cell. For example
Hsp60 is a mitochondrial chaperone residing in the mitochondrial
matrix, which is essential for normal mitochondrial function and
biogenesis. In yeast Hsp60 is found only in the mitochondria; however
in mammalian cells under certain conditions about 15–20% of the
proteins were reported to be outside the mitochondria in proximity
with the plasmamembrane, endoplasmic reticulum (ER), peroxisomes,
and unidentiﬁed cytoplasmic granules/vesicles [47]. Thus Hsp60 may
participate in other cellular activities apart from being a mitochondrial
chaperone. IndeedHsp60 participates in a number of intra/extracellular
activities, with a role in the control of cell survival and cell death. How
Hsp60 is localized outside mitochondria is unknown. A recent study
suggests that under certain conditions Hsp60 can be released from
mitochondria without disruption of either the outer or the inner
mitochondrial membrane yet how this may occur has not been
determined or even speculated [48].
A similar situation is found for the human mitochondrial mtHsp70
homologue, mortalin (see Review in this issue by Azem et al.). In
contrast to normal cells, mortalin was found to be over-expressed and
to be localized in the cytosol of Parkinson, Alzheimer and cancerous
cells [49]. In fact, mortalin has been suggested to perform extra-
mitochondrial functions and has been shown to associate with a
number of unrelated cytosolic proteins [49,50]. Again, as in the case of
Hsp60, how this matrix localized mortalin ends up in the cytosol is
unknown.
3. Rethinking aspects of dual localization
As pointed out in the Introduction, our conventional deﬁnition of
dual targeted mitochondrial proteins refers to situations in which one
of the isoproteins is translocated through/into a mitochondrial
membrane and the second isoprotein is localized to a different
compartment of the cell. Here we brieﬂy refer to other aspects of dual
targeting that may not always ﬁt our initial deﬁnition. In this section
we chose to present some interesting examples that expand our point
of view on the phenomenon of dual localization (Table 2).
3.1. Alternative topogenesis
A protein that is distributed between two subcompartments of the
same organelle is considered to display alternative topogenesis. While
this does not ﬁt our simple deﬁnition of distribution between two
separate compartments of a cell, the mechanisms by which this can
occur are clearly related to the topic of this review.Table 2
Examples of unconventional dual targeting.
Process Example in this
review
Mechanism
Alternative
topogenesis
Mcr1 One product is tail-anchored into the OM; the second
Mgm1 Full length product is embedded in the IM and a clea
Tisssue-speciﬁc
targeting
GS (DF Shark) Two transcrpits by alternative splicing; one includes
GS (chicken) The protein harbors a “weak” MTS whose translocatio
From external
genomes
UL37 (CMV) Ambiguous targeting signal to the ER and mitochond
US9 (CMV) Two targeting signals to the ER and mitochondria on
Map (EPEC) Incomplete import into mitchondria leaves a subpopu
Retargeting of a
protein
p53 Retargeting of a protein from the cytosol to mitchond
cleavage that exposes an MTS.
OM, Outer membrane; IM, Inner membrane; MTS, Mitochondrial targeting sequence.The S. cerevisiae MCR1 gene encodes two mitochondrial isoforms
of NADH–cytochrome b5 reductase: a 34-kDa isoform that is localized
to the outer membrane of mitochondria, and a 32-kDa isoform that
reaches the intermenbrane space [51]. The ﬁrst 12 residues of Mcr1
function as a classical MTS, which is followed by a hydrophobic
sequence. The small isoform crosses the outer membrane via the
translocase of the outer mitochondrial membrane (TOM) complex,
and after interaction with the translocase of the inner mitochondrial
membrane (TIM) complex, is cleaved by the inner membrane
protease (IMP). The other form is tail-anchored in the outer
membrane by a process that does not require any of the TOM
components of the outer membrane. Thus, there is a competition of
the two independent import pathways, which determine the relative
amounts of the two forms.
A second protein, which is localized to more than one compart-
ment within mitochondria, is the yeast dynamin-like GTPase Mgm1.
This protein is distributed between the inner membrane and the
intermembrane space of mitochondria [52]. The presequence of
Mgm1 during translocation through the mitochondrial membranes is
exposed to the matrix and the N-terminal hydrophobic segment
becomes embedded in the inner membrane by a translocation-arrest
mechanism. Subsequently, part of this full-length Mgm1 (l-Mgm1)
molecules undergoes a second proteolytic cleavage by the mitochon-
drial rhomboid protease Pcp1. The resulting shorter, small product, s-
Mgm1, is released into the intermembrane space.
3.1.1. Tissue-speciﬁc targeting
Our simple deﬁnition of dual targeting refers to situations in which
a protein is localized to more than one compartment within a single
cell. Nevertheless, the mechanisms of dual targeting can be employed
to accomplish tissue-speciﬁc targeting; the protein is localized to a
single subcellular compartment but this is a different compartment in
different tissues. The enzyme glutamine synthetase in organisms such
as dogﬁsh shark and chicken is located in different compartments
according to tissue and function. In the liver of these organisms, the
protein catalyzes ammonia detoxiﬁcation, while in neural tissues it
functions in the recycling of the neurotransmitter glutamate.
Although a single gene encodes this protein, its tissue-speciﬁc dual
targeting in the different species is achieved by different mechanisms;
in dogﬁsh shark two different transcripts are generated by tissue-
speciﬁc alternative splicing. The liver transcript contains an alterna-
tive exon that is not present in the neural one. This exon contains an
additional upstream in-frame start codon that leads to the formation
of a mitochondrial-targeting signal [53]. In contrast, in chicken the
single translation product harbors a “weak” mitochondrial-targeting
signal. The suggestedmechanism is that targeting and translocation of
this “weak” signal is dependent on the more negative mitochondrial
membrane potential of the liver versus brain cells. Thus, tissue-
speciﬁc differences in membrane potential lead to localization of
glutamine synthetase in the mitochondria of liver cells and in the
cytosol of brain cells [54].Genes mRNAs Translation
products
is stop transfer embedded in IM. 1 1 1
ved product is released to the IMS. 1 1 1
an MTS, and a shorter one lacks it. 1 2 2
n depends on the IM potential. 1 1 1
ria. 1 1 1
the same protein. 1 1 1
lation in the cytosol. 1 1 1
ria due to binding to Tid1, BclZ or proteolitic 1 1 1
Fig. 3. P53 retargeting to mitochondria. Under stress conditions p53 is stabilized in the
cytosol and targeted both to the nucleus and to mitochondria. Targeting and import of
p53 to/into mitochondria has been proposed to be due to (i) binding to Tid1, which
harbors an MTS and can somehow promote p53 import, (ii) proteolytic cleavage of p53
that exposes an internal MTS or (iii) binding of p53 to the Bcl2 complex on the outer
membrane.
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of a family of transcription factors (CREB/ATF family). This transcrip-
tion factor is important for intracellular signal transduction systems
and it plays a role in the plasticity, growth, and survival of neurons. In
addition to its function in the nucleus, recently it has been shown that
CREB is also localized in the mitochondrial matrix of neurons. CREB
can speciﬁcally bind mitochondrial DNA and it can affect mitochon-
drial transcription, leading to expression of mitochondrial genes and
neuronal survival [55,56]. Nevertheless the full mechanism allowing
the mitochondrial import of the protein only in neurons is still
unknown.
3.1.2. Dual targeting of proteins encoded by external genomes
Dual targeting of proteins is one of the evolutionary solutions of
eukaryotic cells to expand the quantity of protein functions using the
same amount of genes. It is fascinating to see that some pathogens
that are constrained by the number of genes their genomes encode,
use similar tricks of dual targeting.
The human cytomegalovirus (CMV) encodes two dual targeted
proteins. The ﬁrst is the immediate-early protein UL37 exon 1
(pUL37x1), which is dual localized to mitochondria and ER. An
ambiguous signal for targeting is located at the N′ terminus of the
protein which is required for targeting to both organelles [57]. The
second protein, US9 is also dual targeted and localized to mitochon-
dria and the ER. Targeting of this protein is due to two distinct
targeting sequences: an ER targeting signal peptide at the N′ terminus,
and a mitochondrial-targeting sequence located at the C′ terminus
[58].
The EPEC (enteropathogenic Escherichia coli) protein Map is
injected directly into the eukaryotic host cytoplasm via a type III
secretion system. There are a number of cytoplasmic functions
associated with Map such as its ability to trigger Cdc42-dependent
actin rearrangements and disruption of the epithelial barrier function.
The ﬁrst 44 residues of Map are essential for targeting tomitochondria
in a TOM, mtHsp70 and membrane potential dependent manner. It
was suggested that incomplete Map import might be employed to
regulate the levels of mitochondrial versus cytosolic isoproteins. This
regulation may be required to attenuate Map cytoplasmic functions,
which bear toxicity towards the eukaryotic host. However, the
identiﬁcation of a speciﬁc effect for Map on yeast mitochondrial
morphology indicates a speciﬁc function within these organelles [59].
3.1.3. Retargeting of an isoprotein
Is dual or exclusive localization of a protein to speciﬁc compart-
ments in the cell a dead end (unchangeable) process? In fact protein
relocalization is one of the mechanisms that should allow response to
changes within the cell or in its environment. One example is TERT,
the catalytic subunit of telomerase, which plays a role in counter-
acting telomere shortening. Nevertheless, there is evidence for a TERT
function that is telomere-length-independent. Recently it had been
shown that upon oxidative stress, TERT is excluded from the nucleus
and imported into mitochondria. Import of TERT into mitochondria
improves mitochondrial function and protects mitochondrial DNA
from reactive oxygen species (ROS) [60]. An N-terminal targeting
sequence enables import of TERT into mitochondria, but the full
mechanism regulating nuclear import (rather than mitochondrial
import) and then nuclear export is still unknown.
A second example for protein relocalization is P53, which induces
apoptosis both by regulation of its target genes and by signaling
pathways that are transcription independent. As a transcription factor
p53 mediates apoptosis by transcription activation of pro-apoptotic
genes or repression of anti-apoptotic genes. In addition to its transcrip-
tion it has been shown that p53 under speciﬁc cellular conditions is
targeted to mitochondria where it forms an inhibitory complex with the
protective BclXL and Bcl2 proteins, via its DNA binding domain (Fig. 3iii).
These results explain how mutations in p53 have tumor suppressionactivity both via the transcriptional and mitochondrial apoptosis path-
ways [61]. In addition to this interactionwith outermembrane receptors,
andmost relevant to this review, are recent reports that claim that p53 is
translocated into mitochondria, as part of its function as an apoptosis
inducer: i) A recent publication has shown that under hypoxic conditions
p53 speciﬁcally binds to Tid1 (Fig. 3i). Tid1 harbors a speciﬁc N-terminus
mitochondrial-targeting sequence, which under these conditions is
suggested to allow translocation of both proteins to mitochondria by
an unknownmechanism [62]. ii) Intriguingly p53 also was found to be a
substrate of a speciﬁc ser endoprotease. This protease, which also cleaves
CYP1A1 (as described here earlier), cleaves p53 to a 40 kDa fragment and
exposes a cryptic mitochondrial-targeting sequence, suggesting a
mechanism for p53 translocation into mitochondria (Fig. 3ii). iii) p53
has been suggested to regulate the mitochondrial mtDNA copy number.
Although the mechanism which allows p53 translocation into mito-
chondria under these conditions is not clear, this case suggests a function
for p53 in mitochondria [63]. Taken together, p53 may constitute an
example of an extramitochondrial protein that under speciﬁc conditions
is recruited to and translocates into the organelle.
3.2. Perspectives and concluding remarks
We have come a long way from the central dogma of molecular
biology postulating the ﬂow of genetic information, “from one gene to
one mRNA and one protein” and its derivative assumptions of “one
subcellular location and one function”. Today it is clear that a single
gene can encode multiple protein products, and as discussed in this
review, there is substantial information on the fascinating mechan-
isms of dual targeting whether these involve multiple or single
translation products. As discussed in this review it is intriguing that
the isoproteins may have different activities and functions in each
location. Moreover, we now understand that dual targeting is a
dynamic process and that the relative levels of isoproteins can be
rebalanced and that an isoprotein can be retargeted to a completely
different compartment. This allows the cells an important ﬂexibility
and the ability to rapidly react to varying conditions.
What is surprising is the estimation of high abundance of protein
dual targeting in eukaryotic cells ([64] and our unpublished results);
about a quarter of the yeast mitochondrial proteome is predicted to be
dual targeted. This surge in the identiﬁcation of dual targeted proteins
and their mechanisms of distribution is the result of the development
of new and more sensitive methods. In addition to GFP and epitope
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69], mass spectrometry has led to a wide and more accurate
estimation of the whole yeast mitochondrial proteome [70,71]. A
good example of the need for more sensitive methods is “eclipsed
distribution”; the amount of one of the isoproteins, in one of the
locations, is minute and its detection by standard biochemical and
visualization methods is masked by the presence of the dominant
isoprotein [7]. Split genes and speciﬁc isoprotein depletion
approaches are examples of methods that have been developed to
identify such eclipsed distribution [72,73].
Single gene studies, genomic screens referred to above and novel
bioinformatic analysis of mitochondrial genes/proteins, have led to
the estimation of dual targeting as a highly abundant phenomenon.
These studies, mainly in yeast and plants suggest that the phenom-
enon of dual targeting is indeed much more abundant than initially
estimated and in fact hundreds of mitochondrial proteins are
predicted to be dual localized [64,74]. These ﬁndings should reshape
our opinion regarding protein subcellular localization and our full
understanding of gene expression in eukaryotes.
As for the future we certainly need to decipher the mechanism of
known dual targeted proteins as for example in the cases of Hsp60
and mtHsp70 (mortalin); are they exported or released from the
matrix or do they never fully enter the mitochondrial matrix? In
parallel, our expectation is that innovative single gene studies will
lead to the identiﬁcation of novel mechanisms of dual targeting some
of which wemay have considered improbable. Another expectation is
that additional genomic screens, using novel approaches, will be
employed in order to get a better grasp on how widespread the
phenomenon of dual targeting really is.
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